Circulatory arrest after use of sulprostone in post-partum haemorrhage;Circulatiestilstand na gebruik van sulprostone bij fluxus post partum

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 4, 1998, Pages 195-197

  Beerendonk, C C M ^a,b   Massuger, L F A G ^a   Lucassen, A M J ^a,b   Lerou, J G C ^a,b   Van Den Berg, P P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Afd Obstetrie Gynaecologie ^*

Author keywords

[No Author keywords available]

Indexed keywords

SULPROSTONE; ABORTIVE AGENT; DRUG DERIVATIVE; PROSTAGLANDIN E2;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CIGARETTE SMOKING; DRUG CONTRAINDICATION; FEMALE; FRANCE; HEART ARREST; HUMAN; INTRAUTERINE DRUG ADMINISTRATION; POSTPARTUM HEMORRHAGE; RESUSCITATION; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY SPASM; HEART VENTRICLE FIBRILLATION; PREGNANCY; RISK FACTOR;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; CORONARY VASOSPASM; DINOPROSTONE; FEMALE; HEART ARREST; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RESUSCITATION; RISK FACTORS; VENTRICULAR FIBRILLATION;

EID: 0032561831     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ulmann A, Silvestre L. RU486: the French experience. Hum Reprod 1i994:9(Suppl 1):126-30.
2. Kanhai HHH. Keirse MJNC Induction of labour after fetal death: a randomized controlled trial of two prostaglandin regimens. Br J Obstet Gynaecol 1989;96:1400-4
3. Poeschmann RP, Doesburg WH. Eskes TKAB A randomized comparison of oxytocin. sulprostone and placebo in the management of the third stage of labour. Br J Obstet Gynaecol 1991;98:528-30.
4. Farmacotherapeutisch kompas. Amstelveen: Centrale Medisch Pharmaceutische Commissic van de Ziekenfondsraad, 1997:488.
5. College ter Beoordeling van Geneesmiddelen. Nalador. Samenvatting van de kenmerken van het produkt. Rijswijk: College ter Beoordeling van Geneesmiddelen, 1996:1-8.
6. A death associated with mifepristone/sulprostone. Lancet 1991; 337:969-70.
7. Delay M, Genestal M, Carrie D, Livarek B, Boudjemaa B, Bernadet P. Arrêt cardiocirculatoire après administration de l'association mifépristone (Mifégyne) sulprostone (Nalador) pour interruption de grossesse. Rôle évoque du spasme coronaire. Arch Mal Coeur Vaiss 1992;85:105-7.
8. Fliers E, Düren DR, Zwieten PA van. A prostaglandin analogue as a probable cause of myocardial infarction in a young woman [letter]. BMJ 1991,302:416.
9. Kilpatrick AWA, Thorburn J. Severe hypotension due to intramyometrial injection of prostaglandin E2. Anaesthesia 1990;45:848-9.
10. Popat MT, Suppiah N, White JB. Cardiac arrest following intramyometrial injection of prostaglandin E2. Anaesthesia 1991;46:236.
11. Dirken JJD, Vlaanderen W Inversio uteri. Ned Tijdschr Geneeskd 1994;138:38-40.